U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
NYSE:USPH - New York Stock Exchange, Inc. - US90337L1089 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to USPH. USPH was compared to 103 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
In the past year USPH had a positive cash flow from operations.
USPH had positive earnings in each of the past 5 years.
In the past 5 years USPH always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of USPH (2.78%) is better than 62.14% of its industry peers.
USPH has a better Return On Equity (6.60%) than 66.02% of its industry peers.
USPH's Return On Invested Capital of 5.40% is in line compared to the rest of the industry. USPH outperforms 58.25% of its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.78% | ||
| ROE | 6.6% | ||
| ROIC | 5.4% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.69% is fine compared to the rest of the industry. USPH outperforms 75.73% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
With an excellent Operating Margin value of 10.78%, USPH belongs to the best of the industry, outperforming 81.55% of the companies in the same industry.
USPH's Operating Margin has declined in the last couple of years.
USPH has a Gross Margin of 18.74%. This is in the lower half of the industry: USPH underperforms 63.11% of its industry peers.
USPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.78% | ||
| PM (TTM) | 4.69% | ||
| GM | 18.74% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USPH is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
The number of shares outstanding for USPH has been increased compared to 5 years ago.
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.08 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.08, USPH is in line with its industry, outperforming 46.60% of the companies in the same industry.
The Debt to FCF ratio of USPH is 2.98, which is a good value as it means it would take USPH, 2.98 years of fcf income to pay off all of its debts.
USPH's Debt to FCF ratio of 2.98 is fine compared to the rest of the industry. USPH outperforms 77.67% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that USPH is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.32, USPH is doing good in the industry, outperforming 63.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 2.98 | ||
| Altman-Z | 2.08 |
ROIC/WACC0.64
WACC8.42%
2.3 Liquidity
USPH has a Current Ratio of 1.17. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of USPH (1.17) is worse than 65.05% of its industry peers.
USPH has a Quick Ratio of 1.17. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of USPH (1.17) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.82%.
USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
USPH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.30%.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)2.82%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)14.3%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.06%
3.2 Future
USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.71% yearly.
The Revenue is expected to grow by 9.47% on average over the next years. This is quite good.
EPS Next Y0.5%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y10.04%
Revenue Next 3Y9.47%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.91, USPH can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as USPH.
When comparing the Price/Earnings ratio of USPH to the average of the S&P500 Index (27.18), we can say USPH is valued inline with the index average.
A Price/Forward Earnings ratio of 25.21 indicates a quite expensive valuation of USPH.
USPH's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, USPH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.91 | ||
| Fwd PE | 25.21 |
4.2 Price Multiples
USPH's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 64.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.03 | ||
| EV/EBITDA | 12.92 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)58.09
PEG (5Y)N/A
EPS Next 2Y6.46%
EPS Next 3Y8.71%
5. Dividend
5.1 Amount
USPH has a Yearly Dividend Yield of 2.36%.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.52. USPH pays more dividend than 92.23% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 80.88% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP80.88%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
NYSE:USPH (7/16/2025, 1:08:39 PM)
73.72
+0.56 (+0.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.36%
Inst Owner Change0%
Ins Owners1.91%
Ins Owner Change12.64%
Market Cap1.12B
Analysts84.62
Price Target107.3 (45.55%)
Short Float %3.85%
Short Ratio3.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP80.88%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.9%
Min EPS beat(2)-7.64%
Max EPS beat(2)9.44%
EPS beat(4)1
Avg EPS beat(4)-2.94%
Min EPS beat(4)-12.54%
Max EPS beat(4)9.44%
EPS beat(8)2
Avg EPS beat(8)-2.74%
EPS beat(12)4
Avg EPS beat(12)-1.8%
EPS beat(16)8
Avg EPS beat(16)1.16%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.22%
Max Revenue beat(2)1.65%
Revenue beat(4)4
Avg Revenue beat(4)1.02%
Min Revenue beat(4)0.22%
Max Revenue beat(4)1.65%
Revenue beat(8)5
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.12%
Revenue beat(16)8
Avg Revenue beat(16)-0.1%
PT rev (1m)0%
PT rev (3m)-2.59%
EPS NQ rev (1m)1.85%
EPS NQ rev (3m)-6.9%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-3.89%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.91 | ||
| Fwd PE | 25.21 | ||
| P/S | 1.6 | ||
| P/FCF | 20.03 | ||
| P/OCF | 17.01 | ||
| P/B | 2.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.92 |
EPS(TTM)2.55
EY3.46%
EPS(NY)2.92
Fwd EY3.97%
FCF(TTM)3.68
FCFY4.99%
OCF(TTM)4.33
OCFY5.88%
SpS46.05
BVpS32.74
TBVpS-23.33
PEG (NY)58.09
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.78% | ||
| ROE | 6.6% | ||
| ROCE | 7.14% | ||
| ROIC | 5.4% | ||
| ROICexc | 5.61% | ||
| ROICexgc | 34.54% | ||
| OM | 10.78% | ||
| PM (TTM) | 4.69% | ||
| GM | 18.74% | ||
| FCFM | 7.99% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score5
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 2.98 | ||
| Debt/EBITDA | 1.64 | ||
| Cap/Depr | 48.54% | ||
| Cap/Sales | 1.42% | ||
| Interest Coverage | 9.96 | ||
| Cash Conversion | 68.67% | ||
| Profit Quality | 170.42% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.08 |
F-Score5
WACC8.42%
ROIC/WACC0.64
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)2.82%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-5.88%
EPS Next Y0.5%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue 1Y (TTM)14.3%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.06%
Revenue Next Year14.17%
Revenue Next 2Y10.04%
Revenue Next 3Y9.47%
Revenue Next 5YN/A
EBIT growth 1Y12.7%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year34.64%
EBIT Next 3Y16.55%
EBIT Next 5YN/A
FCF growth 1Y10.82%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y13.06%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%